$45.09
0.090.20%
In chiusura: Nov 17, 4:00 PM EST
$45.09
N/A
After hour: 4:00 PM EST
Comments
Loading...
Guidance e previsioni
Supernus Pharmaceuticals fornisce indicazioni su EPS e ricavi futuri, offrendo agli investitori informazioni su quanto la società prevede di guadagnare nei prossimi periodi.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
11/04/2025 | SUPN | Supernus Pharmaceuticals | FY | 2025 | — | — | — | $685.00M | $705.00M | $703.68M | |
08/05/2025 | SUPN | Supernus Pharmaceuticals | FY | 2025 | — | — | — | $670.00M | $700.00M | $632.44M | |
05/06/2025 | SUPN | Supernus Pharmaceuticals | FY | 2025 | — | — | — | $600.00M | $630.00M | $624.69M | |
02/25/2025 | SUPN | Supernus Pharmaceuticals | FY | 2025 | — | — | — | $600.00M | $630.00M | $622.27M | |
11/04/2024 | SUPN | Supernus Pharmaceuticals | FY | 2024 | — | — | — | $630.00M | $650.00M | $619.50M | |
08/06/2024 | SUPN | Supernus Pharmaceuticals | FY | 2024 | — | — | — | $600.00M | $625.00M | $600.12M | |
05/08/2024 | SUPN | Supernus Pharmaceuticals | FY | 2024 | — | — | — | $580.00M | $620.00M | $601.46M | |
02/27/2024 | SUPN | Supernus Pharmaceuticals | FY | 2024 | — | — | — | $580.00M | $620.00M | $622.52M | |
11/08/2023 | SUPN | Supernus Pharmaceuticals | FY | 2023 | — | — | — | $590.00M | $610.00M | $594.28M | |
08/08/2023 | SUPN | Supernus Pharmaceuticals | FY | 2023 | — | — | — | $580.00M | $620.00M | $609.65M | |
05/09/2023 | SUPN | Supernus Pharmaceuticals | FY | 2023 | — | — | — | $580.00M | $620.00M | $599.79M | |
02/28/2023 | SUPN | Supernus Pharmaceuticals | FY | 2023 | — | — | — | $580.00M | $620.00M | $590.51M | |
11/08/2022 | SUPN | Supernus Pharmaceuticals | FY | 2022 | — | — | — | $650.00M | $680.00M | $674.36M | |
08/04/2022 | SUPN | Supernus Pharmaceuticals | FY | 2022 | — | — | — | $640.00M | $680.00M | $673.56M | |
06/09/2022 | SUPN | Supernus Pharmaceuticals | FY | 2022 | — | — | — | $640.00M | $680.00M | $673.56M | |
05/09/2022 | SUPN | Supernus Pharmaceuticals | FY | 2022 | — | — | — | $640.00M | $680.00M | $683.81M | |
04/13/2022 | SUPN | Supernus Pharmaceuticals | FY | 2022 | — | — | — | $640.00M | $680.00M | $685.46M | |
04/04/2022 | SUPN | Supernus Pharmaceuticals | FY | 2022 | — | — | — | $640.00M | $680.00M | $685.46M | |
02/28/2022 | SUPN | Supernus Pharmaceuticals | Q4 | 2021 | — | — | — | $155.00M | $155.00M | $149.42M | |
02/28/2022 | SUPN | Supernus Pharmaceuticals | FY | 2021 | — | — | — | $567.50M | $567.50M | $569.13M | |
02/28/2022 | SUPN | Supernus Pharmaceuticals | FY | 2022 | — | — | — | $640.00M | $680.00M | $707.32M |
FAQ
Qual è la guidance più recente per Supernus Pharmaceuticals (SUPN)?
Negli ultimi mesi non sono state riportate guidance specifiche sulle vendite o sugli utili di Supernus Pharmaceuticals.
Sfoglia guidance e previsioni su tutte le azioni.